December 14th, 2009

Breast Cancer Survival Improves If Herceptin Is Used With Chemotherapy

By Beth Backus

Science Daily
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

Tags: Mayo Clinic Jacksonville

Contact Us · Privacy Policy